The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
New Developments in Messenger Ribonucleic Acids (mRNA) Vaccine Technology: Future Applications in Cancer Oncology
|
|
Author(s): Beredugo Sylvanus (Niger Delta University, Nigeria), Emmanuel Adebola Adebanjo (University of New Haven, USA), Lateef Olawale Fatai (University of Salford, UK), Esther Emarobebh Muojekwu (Niger Delta University, Nigeria), Kafayat Motomori Bakare (University of Salford, UK), Victoria Enemona Oseni (University of Salford, UK)and Ugochukwu Okwudili Matthew (Federal University of Lavras, Brazil)
Copyright: 2025
Pages: 20
Source title:
Cancer Diagnosis, Treatment and Care: Reflections for the Education of Survivors and Healthcare Providers
Source Author(s)/Editor(s): Karis L. Clarke (Touro University California, USA)and Noran L. Moffett (Fayetteville State University, USA)
DOI: 10.4018/979-8-3693-5400-1.ch008
Purchase
|
Abstract
Technological developments in clinical and medical oncology have made it possible to treat certain diseases, like cancer, at the root level through biological processes that requires genes to be transcribed and translated into proteins. The world has learnt about messenger ribonucleic acids(mRNA) technology in the last two years, and in that time, it has shown how quickly it can respond to situations and have almost limitless potential for future uses in the treatment of cancer. The genetic instructions or recipe that guide cells on how to use their own machinery to build proteins are carried by a molecule called messenger RNA (mRNA). This study demonstrated how mRNA can be a powerful tool for developing vaccines and diseases treatments, allowing human cells to put forth a lot of effort in generating proteins that trigger an immune response that defends against illnesses and preserves human organs, marking significant milestone in science and demonstrating the adaptability and versatility of mRNA technology for known and unknown diseases treatments.
Related Content
|
Yiannis Koumpouros.
© 2026.
36 pages.
|
|
Antonios Archontis, Yiannis Koumpouros.
© 2026.
48 pages.
|
|
R Velmurugan, J Sudarvel, Ravi Thirumalaisamy.
© 2026.
24 pages.
|
|
S. Ida Evangeline.
© 2026.
20 pages.
|
|
Ramya Raghavan, Srusti Shankar Moger, SaiMahima Umesh, G N Bhuvana.
© 2026.
36 pages.
|
|
Tiago Manuel Horta Reis da Silva.
© 2026.
32 pages.
|
|
Tiago Manuel Horta Reis da Silva.
© 2026.
32 pages.
|
|
|